Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Programming gene and engineered-cell therapies with synthetic biology2018 · 296 citations
2. 2Phagocytosis and Phagosome Acidification Are Required for Pathogen Processing and MyD88-Dependent Responses to Staphylococcus aureus2010 · 149 citations
3. 3Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-162001 · 302 citations
4. 4MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP2011 · 294 citations
5. 5Immune checkpoint inhibitors: recent progress and potential biomarkers2018 · 2,147 citations